Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 15.444
Filtrar
1.
Infect Dis Poverty ; 13(1): 57, 2024 Aug 02.
Artigo em Inglês | MEDLINE | ID: mdl-39095885

RESUMO

BACKGROUND: Helminth infections, including Opisthorchis viverrini, hookworm, and Trichuris trichiura, are prevalent in Khong district, Champasack province, southern Lao People's Democratic Republic (PDR). Schistosomiasis caused by Schistosoma mekongi is of public health concern on the islands of the Khong district. This study aimed to assess the impact of an Eco-Health/One-Health approach in combination with mass drug administration (MDA) to reduce these helminth infections. METHODS: We conducted a community intervention using a stepped-wedge trial approach on two endemic islands (Donsom and Donkhone) of the Khong district, Champasack province, Lao PDR, between April 2012 and March 2013. In each study village, 30-40 households were randomly selected. All members of selected households, who were at home during the study period were invited to participate in the study. A baseline study was conducted to assess helminth infections, knowledge attitudes and practices toward Schistosoma mekongi infection, behavior of open defecation and availability of latrine at home. After the baseline (T0), the Eco-Health/One-Health approach was implemented on Donsom (intervention) and Donkhone island (control). An assessment was conducted in 2014 (T1), one year after the completion of intervention implementation, to assess the short-term impact of the Eco-Health/One-Health approach on helminth infections and compare intervention and control islands. Later in 2015, the Eco-Health/One-Health approach was implemented on control island (Donkhone). After the implementation of intervention, the parasitological assessments were conducted annually in humans in 2015 (T2), in 2016 (T3) and in 2017 (T4), and in dogs in 2017 (T4) to evaluate the long-term impact of the intervention on helminth infections. Frequency was used to describe the prevalence of helminth infections. Logistic regression was applied to associate the KAP (knowledge, attitudes, and practices and open defecation behavior) and the reduction of helminth infections between intervention and control islands. The reduction in prevalence pre- and post-intervention was associated using a McNemar test. A two-independent sample t-test was applied to compare the mean eggs per gram (EPG) of helminth infections between control and intervention islands. A paired t-test test was used to compare the mean EPG of stool samples before (baseline) and after (follow-up) interventions for the two islands separately. A P-value lower than 0.05 was considered statistically significant. RESULTS: Eco-Health/One-Health approach appears to be associated with reduction in prevalence of S. mekongi by 9.0% [odds ratio (OR) = 0.49, P = 0.003] compared to the use of mass drug administration alone (control island). Additionally, this intervention package significantly reduced O. viverrini infection by 20.3% (OR = 1.92, P < 0.001) and hookworm by 17.9% (OR = 0.71, P = 0.045), respectively. Annual parasitological assessments between 2012 and 2017 showed that the Eco-Health/One-Health approach, coupled with MDA, steadily reduced the prevalence of S. mekongi on the intervention island from 29.1% to 1.8% and on the control island from 28.4% to 3.1%, respectively. CONCLUSIONS: The study findings suggest that the Eco-Health/One-Health approach appears to be associated with a significant reduction in prevalence of S. mekongi and helminth co-infections, particularly hookworm and T. trichiura. Therefore, implementing the Eco-Health/One-Health approach in schistosomiasis-endemic areas could accelerate the achievement of national goals for transmission interruption by 2025 and elimination by 2030.


Assuntos
Helmintíase , Ilhas , Administração Massiva de Medicamentos , Schistosoma , Humanos , Animais , Masculino , Feminino , Laos/epidemiologia , Adulto , Schistosoma/fisiologia , Helmintíase/epidemiologia , Helmintíase/prevenção & controle , Pessoa de Meia-Idade , Adolescente , Adulto Jovem , Criança , Ilhas/epidemiologia , Administração Massiva de Medicamentos/métodos , Anti-Helmínticos/uso terapêutico , Esquistossomose/prevenção & controle , Esquistossomose/epidemiologia , Pré-Escolar , Idoso , Prevalência , Saúde Única
2.
Parasit Vectors ; 17(1): 335, 2024 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-39123250

RESUMO

BACKGROUND: Taenia multiceps coenurosis is endemic in sheep from various regions worldwide. Dogs, the key hosts, shed T. multiceps eggs in their feces contaminating the pasture, and lambs are mostly infected during their first turnout into pastures. The disease is manifested in two forms: acute (due to the migrating oncospheres in the CNS) or chronic (due to the developing coenuri in the brain or spinal cord). Both forms are frequently accompanied by neurological symptoms. METHODS: Field trials conducted in an endemic region (Sardinia, Italy) to treat replacement lambs in six sheep flocks infected with acute coenurosis are summarized in this article. The article also reviews earlier reports on various approaches developed to treat and immunize sheep against coenurosis. RESULTS: Accurate detection of the time in which lambs become infected is crucial in deciding which treatment approach should be used. Acute disease can be successfully treated via chemotherapy. Results of field trials conducted in Sardinia revealed the efficacy of three (1-week apart) oxfendazole doses (14.15 mg/kg) in protecting apparently healthy lambs in the infected flocks from developing neurological symptoms. A single praziquantel dose (18.75 mg/kg) worked well for the same purpose and was also found significant in treating 5 of 16 clinically ill lambs in one flock. Earlier reports documented high rates of recovery (up to 100%) in clinically diseased lambs that received much higher doses (50-100 mg/kg) of praziquantel. However, chemotherapy is not preferred in chronic coenurosis since it can lead to rupture of the coenuri, giving rise to serious inflammation in the CNS. Surgical intervention is highly recommended in this case, and the pooled success rates for surgery in chronic-infected cases was estimated at 82.1% (95% CI 73.1-91.0%). However, various trials have been conducted to immunize sheep against T. multiceps coenurosis, and the 18k (Tm18) family of oncosphere antigens was found promising as a vaccine candidate. CONCLUSIONS: In acute coenurosis, selection of the proper anthelmintic should be done after consulting the owner for several reasons: (1) costs of the used anthelmintic: treating a small flock of 100 sheep costs around 1170 and 660 € for praziquantel and oxfendazole, respectively; (2) withdrawal time of the used anthelmintic: No time is required before consuming meat and milk from praziquantel-treated sheep, whereas meat and milk from oxfendazole-treated sheep should not be consumed for 44 and 9 days, respectively, causing additional costs for the farmers. Since no commercial vaccines have yet been developed against T. multiceps coenurosis in sheep, preventive measures remain the cornerstone of controlling this serious disease.


Assuntos
Surtos de Doenças , Doenças dos Ovinos , Taenia , Animais , Doenças dos Ovinos/parasitologia , Doenças dos Ovinos/tratamento farmacológico , Doenças dos Ovinos/prevenção & controle , Doenças dos Ovinos/epidemiologia , Ovinos , Itália/epidemiologia , Surtos de Doenças/veterinária , Surtos de Doenças/prevenção & controle , Anti-Helmínticos/uso terapêutico , Anti-Helmínticos/administração & dosagem , Doenças Endêmicas/veterinária , Doenças Endêmicas/prevenção & controle , Teníase/veterinária , Teníase/prevenção & controle , Teníase/epidemiologia , Teníase/tratamento farmacológico , Teníase/parasitologia
3.
BMC Pharmacol Toxicol ; 25(1): 48, 2024 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-39123260

RESUMO

BACKGROUND: Addressing critical veterinary drugs, especially drugs with solubility problems like albendazole, and their implications for therapeutic efficacy, in-vitro dissolution studies can indeed provide valuable insights into how different brands of albendazole boluses perform under standardized conditions, helping to assess their dissolution profiles and potential bioavailability. METHODS: Six brands of albendazole 300 mg boluses were collected from December 2020 to May 2021 G.C. The laboratory work was conducted from December 2020 to May 2021 in the National Animal Products and Veterinary Drugs and Feed Quality Assessment Centre (APVD-FQAC) laboratories. The collected brands from government veterinary clinics and private veterinary shops were subjected to model independent and dependent parameters. The dissolution test was conducted according to the USP monograph. RESULTS: The study found that none of the six brands met the requirements of the dissolution test, as their API release was less than 80% within the specified 60-minute timeframe according to USP standards. Model independence indicated that only one brand (Alb002 = 3.72) achieved a difference factor of ≤ 15%. The remaining four brands (4/6) did not meet this criterion. However, the similarity factor (f2) revealed that all five brands (5/6) were comparable to the comparator products, with f2 values of [Formula: see text]50%. The mean dissolution time results confirmed that three brands (3/6) had the highest dissolution rate and the fastest onset of action. The model-dependent kinetics indicated that the Weibull and Korsemeyer-Peppas models were the best fit for the release of drug substances. CONCLUSION: The study highlights issues with albendazole boluses' quality, highlighting the need for national in-vitro dissolution studies. These recommendations could improve quality control, streamline regulatory frameworks, and offer practical, cost-effective methods for evaluating drug efficacy and safety, ensuring veterinary pharmaceuticals meet safety and efficacy standards.


Assuntos
Albendazol , Solubilidade , Albendazol/química , Albendazol/farmacocinética , Albendazol/administração & dosagem , Anti-Helmínticos/química , Anti-Helmínticos/farmacocinética , Anti-Helmínticos/administração & dosagem , Drogas Veterinárias/química , Drogas Veterinárias/farmacocinética , Drogas Veterinárias/administração & dosagem , Liberação Controlada de Fármacos , Animais , Disponibilidade Biológica
4.
Rev Bras Parasitol Vet ; 33(3): e010524, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39140497

RESUMO

This review outlines the current state of anthelmintic resistance (AHR) of gastrointestinal nematodes (GINs) among cattle in Argentina and Brazil, emphasizing the economic repercussions, animal health and welfare. The analysis explores factors associated with AHR and proposes a potential solution: the use of drug combinations. Both countries are grappling with a severe AHR scenario in cattle, having progressed through incipient, established, and advanced phases, leading to extreme cases of animal mortality due to ineffective control strategies. Genera such as Cooperia and Haemonchus have the highest reports of resistance, with Oesophagostomum radiatum also posing significant problems. While oral benzimidazoles and levamisole remain effective in most herds, moxidectin is entering an advanced resistance phase, and avermectins are increasingly deemed ineffective. The review explores the impact ofclimate, mixed grazing, animal movement and other husbandry practices, and the relationship between ectoparasite control and the emergence of resistant helminths. Notably, the discussion includes the strategic use of drug combinations as a valuable approach to address resistant GINs control in livestock, highlighting its significant potential to mitigate the challenges posed by AHR in the cattle industry of these countries.


Assuntos
Anti-Helmínticos , Doenças dos Bovinos , Resistência a Medicamentos , Nematoides , Infecções por Nematoides , Animais , Bovinos/parasitologia , Brasil , Argentina , Doenças dos Bovinos/tratamento farmacológico , Doenças dos Bovinos/parasitologia , Infecções por Nematoides/veterinária , Infecções por Nematoides/tratamento farmacológico , Infecções por Nematoides/parasitologia , Anti-Helmínticos/uso terapêutico , Nematoides/efeitos dos fármacos
5.
Parasitol Res ; 123(8): 299, 2024 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-39141122

RESUMO

To understand the benzimidazole (BZ) resistance of Haemonchus contortus in Southern Xinjiang, three single nucleotide polymorphisms (SNPs) designated as F167Y, E198A, and F200Y, in the isotype-1 ß-tubulin gene which are associated with BZ resistance, were investigated for H. contortus populations from sheep in Hejing and Minfeng counties of Southern Xinjiang. In brief, a total of 190 H. contortus adults were collected from 52 out of 70 slaughtered sheep in city abattoirs across two regions in Southern Xinjiang. The species identity of each adult worm was confirmed by PCR amplification of ITS-2 using H. contortus-specific primers targeting the ITS-2. The samples were then investigated for BZ-related SNPs at locus 167, 198, and 200, by PCR-sequencing of the isotype-1 ß-tubulin gene. The results showed that only E198A and F200Y mutations were detected in the investigated H. contortus populations. The E198A mutation (homozygous and heterozygote resistant: found in 40% and 30% of sequenced samples from Minfeng and Hejing counties, respectively) was predominant compared with the F200Y mutation (homozygous and heterozygote resistant: found in 14% and 13.3% of sequenced samples from Minfeng and Hejing counties, respectively). The results indicate a high prevalence of BZ resistance in H. contortus populations from certain areas of Southern Xinjiang. Our findings provide valuable information for the prevention and control of H. contortus in areas with similar conditions.


Assuntos
Anti-Helmínticos , Benzimidazóis , Resistência a Medicamentos , Hemoncose , Haemonchus , Polimorfismo de Nucleotídeo Único , Doenças dos Ovinos , Tubulina (Proteína) , Animais , Haemonchus/efeitos dos fármacos , Haemonchus/genética , Benzimidazóis/farmacologia , Ovinos , Resistência a Medicamentos/genética , Doenças dos Ovinos/parasitologia , Doenças dos Ovinos/epidemiologia , China/epidemiologia , Tubulina (Proteína)/genética , Hemoncose/veterinária , Hemoncose/parasitologia , Anti-Helmínticos/farmacologia , Análise de Sequência de DNA , DNA Espaçador Ribossômico/genética , Reação em Cadeia da Polimerase
6.
BMC Infect Dis ; 24(1): 778, 2024 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-39097707

RESUMO

BACKGROUND: Albendazole (ABZ) and atovaquone (ATO) achieve killing efficacy on Echinococcus granulosus (Egs) by inhibiting energy metabolism, but their utilization rate is low. This study aims to analyze the killing efficacy of ABZ-ATO loading nanoparticles (ABZ-ATO NPs) on Egs. METHODS: Physicochemical properties of NPs were evaluated by ultraviolet spectroscopy and nanoparticle size potentiometer. In vitro experiments exmianed the efficacy of ATO, ABZ, or ATO-ABZ NPs on protoscolex activity, drug toxicity on liver cell LO2, ROS production, and energy metabolism indexes (lactic dehydrogenase, lactic acid, pyruvic acid, and ATP). In vivo of Egs-infected mouse model exmianed the efficacy of ATO, ABZ, or ATO-ABZ NPs on vesicle growth and organ toxicity. RESULTS: Drug NPs are characterized by uniform particle size, stability, high drug loading, and - 21.6mV of zeta potential. ABZ or ATO NPs are more potent than free drugs in inhibiting protoscolex activity. The protoscolex-killing effect of ATO-ABZ NPs was stronger than that of free drugs. In vivo Egs-infected mice experiment showed that ATO-ABZ NPs reduced vesicle size and could protect various organs. The results of energy metabolism showed that ATO-ABZ NPs significantly increased the ROS level and pyruvic acid content, and decreased lactate dehydrogenase, lactic acid content, and ATP production in the larvae. In addition, ATO-ABZ NPs promoted a decrease in DHODH protein expression in protoscolexes. CONCLUSION: ATO-ABZ NPs exhibits anti-CE in vitro and in vivo, possibly by inhibiting energy production and promoting pyruvic acid aggregation.


Assuntos
Albendazol , Atovaquona , Equinococose , Echinococcus granulosus , Metabolismo Energético , Nanopartículas , Animais , Albendazol/farmacologia , Albendazol/química , Albendazol/administração & dosagem , Camundongos , Metabolismo Energético/efeitos dos fármacos , Echinococcus granulosus/efeitos dos fármacos , Nanopartículas/química , Equinococose/tratamento farmacológico , Equinococose/parasitologia , Atovaquona/farmacologia , Anti-Helmínticos/farmacologia , Anti-Helmínticos/administração & dosagem , Humanos , Tamanho da Partícula , Modelos Animais de Doenças , Feminino
7.
Sci Rep ; 14(1): 18944, 2024 08 15.
Artigo em Inglês | MEDLINE | ID: mdl-39147839

RESUMO

Bilharzia is a parasitic flatworm that causes schistosomiasis, a neglected tropical illness worldwide. Praziquantel (PZQ) is a commercial single treatment of schistosomiasis so alternative drugs are needed to get rid of its side effects on the liver. The current study aimed to estimate the effective role of Ficus carica nanoparticles (Fc-NPCs), silver nanoparticles (Ag-NPCs) and Ficus carica nanoparticles loaded on silver nanoparticles (Fc-Ag NPCs) on C57BL/6 black female mice infected by Schistosoma mansoni and treated with PZQ treatment. It was proved that schistosomiasis causes liver damage in addition to the PZQ is ineffective as an anti-schistosomiasis; it is recorded in the infected mice group and PZQ treated group as in liver function tests, oxidative stress markers & anti-oxidants, pro-inflammatory markers, pro-apoptotic and anti-apoptotic markers also in liver cells' DNA damage. The amelioration in all tested parameters has been clarified in nanoparticle-protected mice groups. The Fc-Ag NPCs + PZQ group recorded the best preemptive effects as anti-schistosomiasis. Fc-NPCs, Ag-NPCs and Fc-Ag NPCs could antagonize PZQ effects that were observed in amelioration of all tested parameters. The study showed the phytochemicals' nanoparticles groups have an ameliorated effect on the health of infected mice.


Assuntos
Ficus , Nanopartículas Metálicas , Praziquantel , Schistosoma mansoni , Esquistossomose mansoni , Prata , Animais , Ficus/química , Camundongos , Praziquantel/farmacologia , Feminino , Schistosoma mansoni/efeitos dos fármacos , Nanopartículas Metálicas/química , Prata/química , Prata/farmacologia , Esquistossomose mansoni/tratamento farmacológico , Esquistossomose mansoni/parasitologia , Camundongos Endogâmicos C57BL , Fígado/parasitologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Cercárias/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Sinergismo Farmacológico , Nanopartículas/química , Extratos Vegetais/farmacologia , Extratos Vegetais/química , Anti-Helmínticos/farmacologia , Anti-Helmínticos/química , Anti-Helmínticos/uso terapêutico
8.
Parasit Vectors ; 17(1): 342, 2024 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-39148111

RESUMO

BACKGROUND: Artemisinin (ART) analogs, such as dihydroartemisinin, arteether, artemether, and artesunate, all featuring an endoperoxide bridge, have demonstrated efficacy against schistosomiasis. Artemisitene (ATT), which contains an additional α, ß-unsaturated carbonyl structure, has shown enhanced biological activities. This study aims to evaluate the anti-schistosomaiasis japonica activity of ATT and compare it with ART. METHODS: We assessed liver inflammation and fibrosis in mice using hematoxylin and eosin staining and Sirius red staining, respectively. RNA sequencing analyzed transcriptomics in female and male Schistosoma japonicum (S. japonicum) adult worms and mice livers, with cytokine profiling and flow cytometry to study immune responses under ART or ATT treatment. RESULTS: ATT exhibits a marked reduction in female S. japonicum adult worms and egg numbers, damaging the adult worms' surface. It also influences the transcription of genes related to cellular anatomical structures. Notably, ATT treatment resulted in significant reductions in liver granuloma size and collagen area, alongside lowering serum levels of glutamic pyruvic and glutamic oxaloacetic transaminase more effectively than ART. Both ART and ATT markedly decreased neutrophil frequency in the liver and elevated eosinophil counts. However, only ATT treatment significantly reduced the M1/M2 and Th1/Th2 indices, indicating a pronounced shift in immune response profiles. ATT-affected host immunity correlated with the extent of liver fibrosis and the count of single males more strongly than ART. CONCLUSION: ATT, as a novel preventive strategy for schistosomiasis japonica in mice, significantly outperforms ART.


Assuntos
Artemisininas , Fígado , Schistosoma japonicum , Esquistossomose Japônica , Animais , Artemisininas/farmacologia , Artemisininas/uso terapêutico , Esquistossomose Japônica/tratamento farmacológico , Esquistossomose Japônica/prevenção & controle , Esquistossomose Japônica/parasitologia , Camundongos , Schistosoma japonicum/efeitos dos fármacos , Feminino , Masculino , Fígado/parasitologia , Fígado/patologia , Fígado/efeitos dos fármacos , Citocinas/metabolismo , Anti-Helmínticos/farmacologia , Anti-Helmínticos/uso terapêutico , Modelos Animais de Doenças
9.
Molecules ; 29(15)2024 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-39124899

RESUMO

Anthelmintic resistance in gastrointestinal nematodes produces substantial challenges to agriculture, and new strategies for nematode control in livestock animals are called for. Natural compounds, including tannins, with proven anthelmintic activity could be a functional option as structurally diverse complementary compounds to be used alongside commercial anthelmintics. However, the dual use of two anthelmintic components requires an understanding of the pharmacological effects of the combination, while information concerning the interactions between plant-based polyphenols and commercial anthelmintics is scarce. We studied the direct interactions of proanthocyanidins (PAs, syn. condensed tannins) and a commercial anthelmintic thiabendazole, as a model substance of benzimidazoles, by isothermal titration calorimetry (ITC). Our results show evidence of a direct interaction of an exothermic nature with observed enthalpy changes ranging from 0 to -30 kJ/mol. The strength of the interaction between PAs and thiabendazole is mediated by structural characteristics of the PAs with the strongest positive correlation originating from the presence of galloyl groups and the increased degree of polymerization.


Assuntos
Anti-Helmínticos , Calorimetria , Proantocianidinas , Tiabendazol , Proantocianidinas/química , Proantocianidinas/farmacologia , Tiabendazol/química , Tiabendazol/farmacologia , Anti-Helmínticos/química , Anti-Helmínticos/farmacologia , Termodinâmica , Animais
11.
Lancet ; 404(10453): 683-691, 2024 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-39153818

RESUMO

BACKGROUND: Human hookworm is a cause of enormous global morbidity. Current treatments have insufficient efficacy and their extensive and indiscriminate distribution could also result in drug resistance. Therefore, we tested the efficacy and safety of emodepside, a strong anthelmintic candidate that is currently undergoing clinical development for onchocerciasis and soil-transmitted helminth infections. METHODS: We conducted a double-blind, superiority, phase 2b, randomised controlled clinical trial comparing emodepside and albendazole. Participants in the emodepside group received six 5 mg tablets of emodepside (totalling 30 mg) and one placebo; participants in the albendazole group received one 400 mg tablet of albendazole and six placebos. Participants were recruited from four endemic villages and three secondary schools in Pemba Island, Tanzania. Participants aged 12-60 years were eligible for treatment if they were positive for hookworm infection, and they had 48 or more eggs per gram from four Kato-Katz thick smears and at least two slides had more than one hookworm egg present. Participants' treatment allocation was stratified by infection intensity and efficacy was measured by cure rate: participants who were hookworm positive and became hookworm negative after treatment. Adverse events were reported at 3 h, 24 h, 48 h, and 14-21 days post-treatment. The trial is registered at ClinicalTrials.gov, NCT05538767. FINDINGS: From Sept 15 to Nov 8, 2022, and from Feb 15 to March 15, 2023, 1609 individuals were screened for hookworm. Of these, 293 individuals were treated: 147 with albendazole and 146 with emodepside. Emodepside demonstrated superiority, with an observed cure rate against hookworm of 96·6%, which was significantly higher compared with albendazole (cure rate 81·2%, odds ratio 0·14, 95% CI 0·04-0·35; p=0·0001). The most common adverse event in the emodepside treatment group was vision blur at 3 h after treatment (57 [39%] of 146). Other common adverse events were vision blur at 24 h after treatment (55 [38%]), and headache and dizziness at 3 h after treatment (55 [38%] for headache and 43 [30%] for dizziness). In the emodepside treatment group, 298 (93%) of the 319 adverse events were mild. The most commonly reported adverse events in the albendazole treatment group were headache and dizziness at 3 h after treatment (27 [18%] of 147 for headache and 14 [10%] for dizziness). No serious adverse events were reported. INTERPRETATION: This phase 2b clinical trial confirms the high efficacy of emodepside against hookworm infections, solidifying emodepside as a promising anthelmintic candidate. However, although the observed safety events were generally mild in severity, considerations must be made to balance the strong efficacy outcomes with the increased frequency of adverse events compared with albendazole. FUNDING: European Research Council.


Assuntos
Albendazol , Anti-Helmínticos , Depsipeptídeos , Infecções por Uncinaria , Humanos , Albendazol/uso terapêutico , Albendazol/efeitos adversos , Tanzânia , Adolescente , Método Duplo-Cego , Masculino , Feminino , Infecções por Uncinaria/tratamento farmacológico , Adulto , Adulto Jovem , Anti-Helmínticos/uso terapêutico , Anti-Helmínticos/efeitos adversos , Anti-Helmínticos/administração & dosagem , Depsipeptídeos/uso terapêutico , Depsipeptídeos/efeitos adversos , Depsipeptídeos/administração & dosagem , Criança , Pessoa de Meia-Idade , Resultado do Tratamento
12.
Trop Biomed ; 41(2): 196-205, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-39154273

RESUMO

Human liver fluke, Opisthorchis viverrini poses a significant risk for development of cholangiocarcinoma (CCA) in Thailand, primarily attributed to consumption of undercooked cyprinoid fishes. The current use of anthelmintic drug treatment such as praziquantel (PZQ), as the main therapeutic agent against O. viverrini. There is a need to explore the efficacy of alternative anthelmintic drugs for O. viverrini treatment. This study aimed to assess the efficacy of anthelmintic drugs, which are commonly use in endemic areas of Southeast Asian countries; PZQ, albendazole (AL), niclosamide (NI), and mebendazole (ME) at concentrations of 600, 400, 500, and 500 mg/ml. The study included a negative and positive control group treated with roswell park memorial institute (RPMI) and PZQ. Reactive oxygen species (ROS) levels, indicative of oxidative stress, were quantified using 2',7'-dichlorofluorescein diacetate staining. Morphological changes were observed using scanning electron microscopy. Furthermore, motility assessments were conducted at various time points (0, 5, 30 minutes, 1, 3, 6, 12, and 24 hours), calculating relative motility (RM) and survival index (SI). The results revealed a significant increase of ROS levels with the intensity and corrected total worm fluorescence (CTWF) mostly observed in order of PZQ, followed by NI, ME, and AL, respectively. Morphological damage was presented the tegumental swelling, papillae changes, and disruption of microvilli (Mv), particularly in the group treated with the most effective anthelmintics PZQ, NI, ME, and AL, while negative control group did not exhibit such alterations. Also, the most efficacy for suppressing the motility of adult worms were displayed in PZQ treatment group, followed by NI, ME, and AL, respectively. Overall, first novel findings suggest that apart from NI, ME, and AL demonstrate potential as alternative therapeutic options for O. viverrini infection. Furthermore, animal model is needed to investigate the efficacy of NI, ME, and AL compare with standard treatment.


Assuntos
Albendazol , Anti-Helmínticos , Niclosamida , Opistorquíase , Opisthorchis , Espécies Reativas de Oxigênio , Animais , Opisthorchis/efeitos dos fármacos , Anti-Helmínticos/farmacologia , Niclosamida/farmacologia , Opistorquíase/tratamento farmacológico , Espécies Reativas de Oxigênio/metabolismo , Albendazol/farmacologia , Praziquantel/farmacologia , Mebendazol/farmacologia , Tailândia , Estresse Oxidativo/efeitos dos fármacos
13.
Int J Health Policy Manag ; 13: 7842, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39099510

RESUMO

Over the last five decades, widespread industrialisation and urbanisation have resulted in the influx of low-skilled workers, particularly from Southeast and West Asia to Malaysia. The current practice for migrant workers entry for employment requires mandatory medical screening for infectious diseases. However, screening for parasitic infections in Malaysia is woefully inadequate. Many migrants come from low-income countries where parasitic infections are common, which may have public health implications for their overall well-being as parasitic infections, although not critical, may impact their overall productivity. The high prevalence of intestinal parasitic infections (IPIs) recorded among migrant workers in Malaysia necessitates improvement in the national health policy to include mandatory mass administration of a single dose of anthelmintic drugs to all low-skilled migrant labourers, particularly upon entry into the country, admission, and encourage continuous surveillance. A constant stream of migrant labourers is anticipated, potentially resulting in an ongoing occurrence of parasitic infections within the population. The implementation of economic measures like health awareness initiatives, routine deworming campaigns, and improved sanitation facilities holds the potential to reduce the spread of these infections notably. More often than not, taking preventive actions proves to be more financially efficient over time compared to addressing severe infections at a later stage.


Assuntos
Enteropatias Parasitárias , Migrantes , Humanos , Malásia/epidemiologia , Migrantes/estatística & dados numéricos , Enteropatias Parasitárias/prevenção & controle , Enteropatias Parasitárias/tratamento farmacológico , Enteropatias Parasitárias/epidemiologia , Administração Massiva de Medicamentos , Anti-Helmínticos/administração & dosagem , Anti-Helmínticos/uso terapêutico , Política de Saúde , Prevalência
16.
PLoS Negl Trop Dis ; 18(8): e0012324, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-39088567

RESUMO

BACKGROUND: Soil-transmitted helminth (STH) infections, commonly caused by roundworms (Ascaris lumbricoides), whipworms (Trichuris trichiura), and hookworms (Necator americanus and Ancylostoma duodenale), were widespread among Ugandan schoolchildren in the late 1990s and early 2000s. Since 2003, the Ugandan Ministry of Health has administered biannual preventive chemotherapy to children aged 1-14 years to control these infections. Twenty years after the program's inception, there is scant data to show the long-term impact of these national deworming efforts. METHODS: To estimate the prevalence and intensity of STH infections among 10-14-year-old primary school children, school-based, cross-sectional surveys were conducted in November 2023 across five districts (Kamwenge, Sheema, Adjumani, Lamwo, and Zombo). Sixty-five children from five schools per district were selected for inclusion. Fecal egg counts were determined using the Kato-Katz microscopy technique, performed in duplicate by trained laboratory technicians. RESULTS: The survey findings revealed a high prevalence of any STH infection in Kamwenge District (21.2%, 95% confidence limits (CL): 5.7%, 36.6%), while the remaining four districts exhibited lower prevalences, ranging from 0.4% (95% CL: 0.0%, 1.2%) in Adjumani District to 5.6% (95% CL: 0.0%, 11.4%) in Sheema District. The prevalence of moderate-to-heavy-intensity infections was below 1% across all districts. A. lumbricoides was identified infrequently. Hookworm infections were primarily identified in the western districts of Kamwenge and Sheema, while T. trichiura infections were common only in Kamwenge District. Hookworm and T. trichiura infections were uncommon in the northern districts of Adjumani, Lamwo, and Zombo. CONCLUSIONS: These surveys suggest that morbidity due to STH infections among schoolchildren may be well controlled in these five districts, as evidenced by low moderate-to-heavy-intensity infection prevalence. However, the prevalence of any intensity infection remains elevated in some districts, indicating the need for continued preventive chemotherapy distribution. A reduction from biannual treatment may be warranted in four districts, per World Health Organization recommendations.


Assuntos
Helmintíase , Solo , Humanos , Uganda/epidemiologia , Criança , Prevalência , Solo/parasitologia , Animais , Feminino , Estudos Transversais , Masculino , Helmintíase/epidemiologia , Helmintíase/transmissão , Adolescente , Fezes/parasitologia , Instituições Acadêmicas , Ascaris lumbricoides/isolamento & purificação , Trichuris/isolamento & purificação , Ancylostoma/isolamento & purificação , Anti-Helmínticos/uso terapêutico , Anti-Helmínticos/administração & dosagem , Tricuríase/epidemiologia , Helmintos/isolamento & purificação , Helmintos/classificação
17.
Retina ; 44(8): 1456-1462, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-39047132

RESUMO

PURPOSE: To report optical coherence tomography findings of presumed veterinary anthelmintic drugs (VADs)-induced retinal toxicity that may aid in understanding potential pathogenic mechanisms. METHODS: This is a retrospective observational case series analysis of patients with vision abnormalities following the accidental or intentional consumption of veterinary anthelmintic drugs. All cases underwent a thorough ophthalmological examination. Moreover, medical records, as well as the initial and follow-up optical coherence tomography images, were thoroughly scrutinized. RESULTS: Four patients were identified (3 men; mean [range] age, 36.5 [22-52] years). Each patient overdosed on one or two of the following VADs: closantel, triclabendazole, praziquantel, pyrantel pamoate, and niclofolan. The most characteristic optical coherence tomography finding was diffuse, granular, hyperreflective lesions throughout the outer retina, which were initially identified in the ellipsoid zone in two cases. At follow-up, optical coherence tomography exhibited regression of hyperreflective lesions and extensive loss of the outer retinal elements in two patients. In addition, the subfoveal outer retinal layers may be partially preserved. CONCLUSION: Some veterinary anthelmintic drugs could be detrimental to the human retina if overdosed, resulting in visual disturbances. Optical coherence tomography revealed the mitochondria-enriched ellipsoid zone where outer retinal damage first appeared on, implying that these medications may harm the retina by inhibiting mitochondrial energy metabolism, as they do to eliminate parasites.


Assuntos
Anti-Helmínticos , Doenças Retinianas , Tomografia de Coerência Óptica , Tomografia de Coerência Óptica/métodos , Humanos , Estudos Retrospectivos , Adulto , Pessoa de Meia-Idade , Masculino , Anti-Helmínticos/toxicidade , Feminino , Adulto Jovem , Doenças Retinianas/induzido quimicamente , Doenças Retinianas/diagnóstico , Drogas Veterinárias/toxicidade , Retina/efeitos dos fármacos , Retina/patologia , Acuidade Visual , Salicilanilidas/toxicidade , Triclabendazol , Praziquantel/toxicidade
18.
PLoS Negl Trop Dis ; 18(7): e0012331, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38995979

RESUMO

BACKGROUND: Soil-transmitted helminthiases (STHs) are common in tropical and subtropical regions. Southern Thailand experiences an extended rainy season, leading to persistently moist soil. This condition supports the life cycle of STHs, hindering effective control due to reinfection and low drug efficacy. We implemented a novel STH control strategy during the dry season aimed at decreasing reinfection rates without enhancing sanitation or hygiene practices. However, there were unexpected, prolonged droughts linked to El Niño events from 2014 to 2016. Additionally, we assessed the effects of these drought conditions on further control measures without the use of anthelmintics. METHODOLOGY/PRINCIPAL FINDINGS: A longitudinal study was conducted from 2012 to 2016. Stool samples collected from 299 participants were analyzed using the Kato-Katz and agar plate culture methods. Participants who tested positive for STHs received a single 400 mg dose of albendazole. The efficacy of the treatment was evaluated three weeks later. To confirm the control measures were implemented during the dry season, we monitored the number of rainy days following albendazole treatment for 52 days, of which 38 were without rain. Follow-up stool examinations were carried out in 2013 and 2016, with no additional doses of albendazole administered. Rainfall and rainy day data, which served as indicators of unexpected droughts due to El Niño, were collected from the nearest local meteorological stations. Before the drought, there was a decrease in STH prevalence in 2013-except for trichuriasis-attributable to the dry season control efforts. Despite these efforts, STH prevalence remained high. Remarkably, in 2016, following the drought period, the prevalence of trichuriasis, which had not changed previously, spontaneously declined without further albendazole treatment compared to 2013. Furthermore, the prevalence of strongyloidiasis remained unchanged likely due to its low susceptibility to drought conditions, as it can reproduce within hosts. Conversely, the prevalence of other STHs consistently declined. The drought and possible improvements in sanitation and hygiene practices contributed to this decrease by reducing rates of reinfection and new infection and by increasing the natural cure rate. Additionally, some participants infected with hookworms or Trichuris who were not cured by albendazole experienced natural remission. CONCLUSIONS/SIGNIFICANCE: Control measures implemented during the dry season, combined with a 14-month-long drought induced by the El Niño event of 2014-2016, and some improvements in sanitation and hygiene practices, contributed to a decrease in both the prevalence and intensity of STHs, except for S. stercoralis. Over time, S. stercoralis is likely to become the predominant species among the STHs.


Assuntos
Albendazol , Anti-Helmínticos , Secas , El Niño Oscilação Sul , Fezes , Helmintíase , Solo , Estudos Longitudinais , Humanos , Solo/parasitologia , Tailândia/epidemiologia , Masculino , Feminino , Albendazol/uso terapêutico , Albendazol/administração & dosagem , Adulto , Adolescente , Helmintíase/tratamento farmacológico , Helmintíase/epidemiologia , Helmintíase/transmissão , Helmintíase/prevenção & controle , Helmintíase/parasitologia , Anti-Helmínticos/uso terapêutico , Anti-Helmínticos/administração & dosagem , Adulto Jovem , Fezes/parasitologia , Criança , Pessoa de Meia-Idade , Animais , Estações do Ano , Pré-Escolar
19.
BMC Infect Dis ; 24(1): 661, 2024 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-38956479

RESUMO

BACKGROUND: After decades of praziquantel mass drug administration (MDA), several countries approach schistosomiasis elimination. Continuing MDA in largely uninfected populations no longer seems justified. Alternative interventions to maintain the gains or accelerate interruption of transmission are needed. We report results, strengths, and shortcomings of novel test-treat-track-test-treat (5T) interventions in low Schistosoma haematobium prevalence areas on Pemba, Tanzania. METHODS: School- and household-based surveys were conducted in 2021 and 2022 to monitor the S. haematobium and microhematuria prevalence and assess the impact of interventions. In 2021, 5T interventions were implemented in 15 low-prevalence areas and included: (i) testing schoolchildren in primary and Islamic schools for microhematuria as a proxy for S. haematobium, (ii) treating positive children, (iii) tracking them to their households and to water bodies they frequented, (iv) testing individuals at households and water bodies, and (v) treating positive individuals. Additionally, test-and-treat interventions were implemented in the 22 health facilities of the study area. RESULTS: The S. haematobium prevalence in the school-based survey in 15 low-prevalence implementation units was 0.5% (7/1560) in 2021 and 0.4% (6/1645) in 2022. In the household-based survey, 0.5% (14/2975) and 0.7% (19/2920) of participants were infected with S. haematobium in 2021 and 2022, respectively. The microhematuria prevalence, excluding trace results, in the school-based survey was 1.4% (21/1560) in 2021 and 1.5% (24/1645) in 2022. In the household-based survey, it was 3.3% (98/2975) in 2021 and 5.4% (159/2920) in 2022. During the 5T interventions, the microhaematuria prevalence was 3.8% (140/3700) and 5.8% (34/594) in children in primary and Islamic schools, respectively, 17.1% (44/258) in household members, and 16.7% (10/60) in people at water bodies. In health facilities, 19.8% (70/354) of patients tested microhematuria-positive. CONCLUSIONS: The targeted 5T interventions maintained the very low S. haematobium prevalence and proved straightforward and feasible to identify and treat many of the few S. haematobium-infected individuals. Future research will show whether 5T interventions can maintain gains in the longer-term and expedite elimination. TRIAL REGISTRATION: ISRCTN, ISCRCTN91431493. Registered 11 February 2020, https://www.isrctn.com/ISRCTN91431493 .


Assuntos
Anti-Helmínticos , Administração Massiva de Medicamentos , Praziquantel , Schistosoma haematobium , Esquistossomose Urinária , Tanzânia/epidemiologia , Esquistossomose Urinária/tratamento farmacológico , Esquistossomose Urinária/epidemiologia , Esquistossomose Urinária/prevenção & controle , Humanos , Criança , Animais , Schistosoma haematobium/efeitos dos fármacos , Adolescente , Masculino , Praziquantel/uso terapêutico , Praziquantel/administração & dosagem , Feminino , Prevalência , Administração Massiva de Medicamentos/métodos , Anti-Helmínticos/uso terapêutico , Anti-Helmínticos/administração & dosagem , Erradicação de Doenças/métodos , Instituições Acadêmicas , Adulto , Características da Família , Hematúria , Adulto Jovem
20.
Parasit Vectors ; 17(1): 296, 2024 Jul 09.
Artigo em Inglês | MEDLINE | ID: mdl-38982488

RESUMO

The population of South American camelids (SAC) has been steadily growing in Europe, where they are confronted with the regional endoparasite population of ruminants. As there are no anthelmintic drugs registered for use against nematode infections in SACs, anthelmintics (AH) available for ruminants or horses are usually applied. Reports indicating potential failures in administered AH are increasing. However, the generally low egg counts in SACs complicate the application of resistance tests in the field. The present study reports a follow-up study on SAC farms where anthelmintic resistance (AR) was suspected. The aims were (i) to repeat faecal egg count reduction tests (FECRTs) on potentially affected farms identified in a previous study with larger sample sizes, (ii) to verify suspected AR of Haemonchus contortus against benzimidazoles (BZ) by performing a single-nucleotide polymorphism (SNP) analysis using digital polymerase chain reaction (dPCR), and (iii) to apply the mini-FLOTAC technique for more reliable results at low egg counts in line with current recommendations. Seven farms (9-46 animals each) were examined by coproscopy, larval differentiation and SNP analysis. A FECRT was performed on six of these farms with moxidectin (three farms), monepantel (two farms) and ivermectin (one farm). The FEC was calculated according to the current World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines with the clinical protocol (a newly introduced variant of FECRT which can be used for smaller sample sizes and lower egg counts on the cost of sensitivity) and an expected efficacy of 99%. A high level (> 90%) of BZ-resistance-associated SNPs on codon 200 of H. contortus was observed on all farms. With the FECRT, resistance was demonstrated for ivermectin (74% FECR), while it remained inconclusive for one farm for moxidectin treatment. Sustained efficacy was demonstrated for the remaining treatments. This study showed an advanced level of BZ resistance in H. contortus of SACs and the development of AR against macrocyclic lactones on some farms. Thus, constant monitoring of AH treatment and sustainable worm control methods both need to be applied.


Assuntos
Anti-Helmínticos , Benzimidazóis , Camelídeos Americanos , Resistência a Medicamentos , Fezes , Hemoncose , Haemonchus , Contagem de Ovos de Parasitas , Animais , Haemonchus/efeitos dos fármacos , Haemonchus/genética , Resistência a Medicamentos/genética , Anti-Helmínticos/farmacologia , Hemoncose/veterinária , Hemoncose/parasitologia , Hemoncose/tratamento farmacológico , Contagem de Ovos de Parasitas/veterinária , Benzimidazóis/farmacologia , Fezes/parasitologia , Camelídeos Americanos/parasitologia , Alelos , Polimorfismo de Nucleotídeo Único , Lactonas/farmacologia , Alemanha , Macrolídeos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...